Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Martin Mcglynn Insider Profile
4 Followers
Martin Mcglynn, President & CEO, Director at Microbot Medical, holds 2.26M shares in Microbot Medical (Ticker: MBOT). Most recently, Martin Mcglynn Bought $236,736 shares of Microbot Medical on Jan 12, 2016 for an estimated value of 89.96K.
Martin Mcglynn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Martin Mcglynn holds in companies
Most Profitable Insider Trade
The most profitable trade made by Martin Mcglynn
Martin Mcglynn's Trading History
List of latest transactions for each holding click on a transaction to see Martin Mcglynn's performance on stock
You May Also Like
Martin Mcglynn insider profile FAQ
What is the percentage of profitable transactions made by Martin Mcglynn?
The percentage of profitable transactions made by Martin Mcglynn is ―.
What is the average return per transaction made by Martin Mcglynn?
The average return per transaction made by Martin Mcglynn is ―.
What stocks does Martin Mcglynn hold?
Martin Mcglynn holds: MBOT stocks.
What was Martin Mcglynn’s latest transaction?
Martin Mcglynn latest transaction was an Informative Buy of $89.96K.
What was Martin Mcglynn's most profitable transaction?
Martin Mcglynn’s most profitable transaction was an Informative Buy of MBOT stock on January 12, 2016. The return on the trade was -83.80%.
What is Martin Mcglynn's role in Microbot Medical?
Martin Mcglynn's role in Microbot Medical is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.